FDA Person
Center for Drug Evaluation and ResearchErika V. Butler
View detailed information about Erika V. Butler, including compliance records, violations, and related data.
Person Profile
Comprehensive profile of Erika V. Butler, including their role, qualifications, and regulatory activities.
Recent Records (26)
Page 1 of 2WARNING_LETTER - Jiangsu Hengrui Pharmaceuticals Co., Ltd.
WARNING_LETTER
WARNING_LETTER - Intas Pharmaceuticals Limited
WARNING_LETTER
WARNING_LETTER - Rechon Life Science AB
WARNING_LETTER
483 - fusion iv pharmaceuticals, inc.
483
483 - Fagron Compounding Services
483
483 - US Compounding Inc
483
483 - University Pharmacy, Inc.
483
483 - Brown's Compounding Center, Inc.
483
483 - University of Washington Inpatient Pharmacy
483
483 - Isomeric Pharmacy Solutions, LLC
483
483 - Wiley Chemists Inc.
483
483 - Corden Pharma Boulder, Inc.
483
483 - Belmar Pharmacy
483
WARNING_LETTER - MAKRA KOZMETIKA D.O.O.
WARNING_LETTER
483 - Sandoz Incorporated
483
AMENDED_483 - fusion iv pharmaceuticals, inc.
AMENDED_483
483_RESPONSE - Isomeric Pharmacy Solutions, LLC
483_RESPONSE
EIR - Zhejiang Tianyu Pharmaceutical Co., Ltd.
EIR
EIR - AGILENT TECHNOLOGIES INC./US
EIR
483 - Agilent Technologies Inc
483
Showing 1-20 of 26 records
Related People (5)
Related Office
Person Information
Name
Erika V. Butler
Title
Compliance Officer / Investigator
Role
Regulatory Personnel
ID: 3e654530-4c29-403d-880e-a5422315c3c0
Get More Insights
Access our comprehensive regulatory intelligence platform to analyze patterns, track compliance trends, and stay ahead of regulatory changes.
1.5M+ regulatory data points
Real-time compliance monitoring
Interactive analytics dashboard
Looking for more people? Our platform provides access to thousands of FDA people with advanced search and filtering capabilities.
Transform Regulatory Data into Actionable Intelligence
Join leading pharmaceutical and medical device companies who trust GKS for their regulatory compliance needs.
Try KeyPedia Today
Explore our real use cases and discover our features in depth.
Subscribe to our newsletter
Get the latest updates and insights delivered to your inbox